OBSmart

Company Overview

Snapshot

Founded in May 2016 by Ali Stern-cohen and Ran Stern, OBSmart operates with 1–10 employees. The company has secured funding across one round from The Trendlines Group. In January 2019, OBSmart received investment from The Trendlines Group.

Business overview

OBSmart is a Health Tech & Life Sciences company developing a mobile medical device designed to measure cervical dilation at home. This technology aims to assist midwives and pregnant women in detecting true labor and determining readiness for birth, thereby preventing unnecessary hospital visits. The company operates in the Digital Healthcare and Medical Devices sectors, focusing on digital medical diagnostics and diagnostic devices, serving global markets with B2C and B2B business models.

Company Intelligence Q&A

What is OBSmart's primary product?

OBSmart is developing a mobile medical device for home-use cervical dilation measurement, intended to help pregnant women and midwives determine the onset of true labor and readiness for birth.

When was OBSmart founded and by whom?

OBSmart was founded in May 2016 by co-founders Ali Stern-cohen, who also serves as CEO, and Ran Stern.

What is the current operational status of OBSmart?

OBSmart is currently non-active and ceased to operate in May 2024.

What markets does OBSmart target?

OBSmart targets global markets, operating with both B2C and B2B business models in the digital healthcare and medical devices sectors.